1.Survey on prevalence of atopic dermatitis in 0 - 6 year-old children in Tianjin
San-Wu ZENG ; Pj COENRAADS ; Nai-Jun TANG ; Li-Ming JI ; Wen-Xin GAO ; Dan XI ; Jing-Ji JIN ; Wen-guo WEI
Chinese Journal of Dermatology 1995;0(04):-
Objective To investigate the prevalence of and predisposing factors of atopic dermatitis (AD ) in 0 - 6 year-old children in rural and urban area of Tianjin. Methods The subjects were chosen by cluster sampling from kindergartens in Tianjin's urban and rural districts. Questionnaires were designed based on the International Study of Asthma and Allergies in Children (ISAAC ) and distributed to the children's parents via the teachers. Results In this survey, 3 749 questionaires were returned, of which 3 708 were valid. The response rate was 82.7% in total, 79.3% in the rural area, and 84.9% in the urban area. The age and gender distributions were similar in the urban and rural area. The prevalence rate of AD in these children was 2.9% in total, and it was higher in the urban area than in the rural area (3.5% vs 2.4%, x2 = 3.98, P
2.Development and clinical application of the EMG information management system.
Qiang ZHANG ; Zeng CAI ; Guang-yu DENG ; Mao-yue ZHANG ; San-chun YU ; Seng-gang SUN ; Yuan-wu MEI
Chinese Journal of Medical Instrumentation 2002;26(3):192-224
This paper introduces an EMG multi-gateway analysis diagnosis and information management system. The clinical applications show that this system has higher efficiency and standard report contents, and easy statistical analysis. And it also offers EMG standard figure, normal value data, nerve and muscle select scheme etc, for reference.
Automatic Data Processing
;
Computers
;
Electromyography
;
instrumentation
;
methods
;
Equipment Design
;
Humans
;
Information Storage and Retrieval
;
methods
;
Management Information Systems
;
Medical Records Systems, Computerized
;
standards
;
Software
3.Correlation of casein kinase 2β overexpression to the metastatic ability of colorectal cancer cells in vitro.
Jin-Jin ZOU ; He-San LUO ; Zhi-Yong HUANG ; Zhong-Yi DONG ; Qin ZENG ; De-Hua WU
Journal of Southern Medical University 2011;31(4):628-632
OBJECTIVETo investigate the expression of casein kinase 2β (ck2β) in colorectal cancer in relation to the metastatic ability of the cancer cells.
METHODSThe expression of ck2β in 46 normal colorectal mucosa, 20 colorectal adenomas and 66 colorectal cancers were detected immunohistochemically. In colorectal cancer cells, Ck2β protein expression was knockdown by RNA interference using ck2β-specific small interfering RNA (siRNA) and the interference efficiency was assessed by Western blotting. The effect of ck2β gene knockdown on the proliferation of the colorectal cancer cells was tested with colony formation assay, and the changes in the invasive ability of the cells were observed using Transwell chamber assay.
RESULTSNegative or weak ck2β expression was detected in normal colorectal mucosa, with nuclear positivity in 8.7% and cytoplasmic positivity in 13.0% of the cases. Colorectal adenomas showed moderate ck2β expression, with 60% cases showing positivity in the cell nuclei and 40% in the cytoplasm. In colorectal cancers, significantly stronger expression of ck2β was found than that in colorectal adenomas and normal colorectal mucosa (P<0.05), and 75.8% cases showed positivity in the cell nuclei and 62.1% showed cytoplasmic positivity; the expression of ck2β protein in colorectal cancers with lymph node metastasis was even higher (P<0.05). Ck2β knockdown obviously inhibited the proliferation and invasiveness of colorectal cancer cells in vitro.
CONCLUSIONThe high expression of ck2β in colorectal cancer is closely correlated to the carcinogenesis and metastasis of the tumor.
Adult ; Aged ; Casein Kinase II ; metabolism ; Cell Proliferation ; Cell Transformation, Neoplastic ; Colorectal Neoplasms ; metabolism ; pathology ; Female ; Humans ; Intestinal Mucosa ; metabolism ; pathology ; Male ; Middle Aged ; Tumor Cells, Cultured ; Young Adult
4.Cox regression analysis on influencing factors of coronary heart disease among people over 40 years of age.
Hao LIU ; Li-Guang ZHU ; Wei-Hong SU ; Ke-Jiang QIN ; Ming PANG ; Jian-Jian LU ; Guang-Wei WU ; Ji-Jin ZHU ; Xin-Zhi TAO ; Xing-San LI ; Zhi-Heng ZENG
Chinese Journal of Epidemiology 2005;26(12):964-966
OBJECTIVETo explore the affecting factors on coronary heart disease among people over 40 years of age in Guangxi area, China.
METHODSBaseline data was gathered through the Third National Blood Pressure Survey in 1991 in China. A total number of 11 818 adults over 40 years old had been studied in Guangxi province. Data of morbidity and mortality of coronary heart disease was obtained.
RESULTSCardiovascular events were related to systolic blood pressure, diastolic blood pressure, pulse pressure, smoking, BMI regardless of their myocardial infarct (MI) history. Cox regression analysis showed that the relative risk for cardiovascular events increased by 21 [95% confidence interval (CI): 9.06-48.44] times for those people having MI history. When pulse pressure, systolic blood pressure, diastolic blood pressure increased by every 10 mm Hg, the relative risk for cardiovascular events increased by 1.29 (95% CI: 1.11-1.49), 1.18 (95% CI: 1.02-1.22), 1.13 (95% CI: 1.05-1.28) respectively. There was 1.23 (95% Cl: 1.05-1.45) times higher in smoker than non-smoker on relative risk for cardiovascular events. When BMI increasing 1, the relative risk for cardiovascular events would increase 1.03 (95% CI: 1.01-1 .05) times.
CONCLUSIONHypertension, smoking, increase of BMI were the risk factors of coronary heart disease among people who were over 40 years of age.
Adult ; Body Mass Index ; China ; epidemiology ; Cohort Studies ; Confidence Intervals ; Coronary Disease ; epidemiology ; etiology ; Health Surveys ; Humans ; Hypertension ; complications ; Myocardial Infarction ; Proportional Hazards Models ; Risk Factors ; Smoking ; adverse effects
5.Analysis of dyslipidemia management status in atrial fibrillation patients with very high and high risk of atherosclerotic cardiovascular disease.
San Shuai CHANG ; Jia Hui WU ; Jing CUI ; Chang HUA ; Shi Jun XIA ; Liu HE ; Xu LI ; Man NING ; Rong HU ; Xin DU ; Jian Zeng DONG ; Chang Sheng MA
Chinese Journal of Cardiology 2023;51(6):642-647
Objective: To analyze the status of statins use and low-density lipoprotein cholesterol (LDL-C) management in patients with atrial fibrillation (AF) and very high/high risk of atherosclerotic cardiovascular disease (ASCVD) from Chinese Atrial Fibrillation Registry (CAFR). Methods: A total of 9 119 patients with AF were recruited in CAFR between January 1, 2015 to December 31, 2018, patients at very high and high risk of ASCVD were included in this study. Demographics, medical history, cardiovascular risk factors, and laboratory test results were collected. In patients with very high-risk, a threshold of 1.8 mmol/L was used as LDL-C management target and in patients with high risk, a threshold of 2.6 mmol/L was used as LDL-C management target. Statins use and LDL-C compliance rate were analyzed, multiple regression analysis was performed to explore the influencing factors of statins use. Results: 3 833 patients were selected (1 912 (21.0%) in very high risk of ASCVD group and 1 921 (21.1%) in high risk of ASCVD group). The proportion of patients with very high and high risk of ASCVD taking statins was 60.2% (1 151/1 912) and 38.6% (741/1 921), respectively. Attainment rate of LDL-C management target in patients with very high and high risk were 26.7% (511/1 912) and 36.4% (700/1 921), respectively. Conclusion: The proportion of statins use and attainment rate of LDL-C management target are low in AF patients with very high and high risk of ASCVD in this cohort. The comprehensive management in AF patients should be further strengthened, especially the primary prevention of cardiovascular disease in AF patients with very high and high risk of ASCVD.
Humans
;
Atrial Fibrillation/drug therapy*
;
Cardiovascular Diseases
;
Cholesterol, LDL
;
Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*
;
Atherosclerosis
;
Dyslipidemias/drug therapy*